InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: medchem post# 13785

Monday, 02/22/2021 1:10:23 PM

Monday, February 22, 2021 1:10:23 PM

Post# of 16706
We are a small company and would be kaput as BTH if not for the redirection to repurposed drugs. Dr MW found research and a reasonable path to target lung issues with ifenprodil. COVID enhanced the effort. Many discussed the proposed science.
The CT was not the knock-out we all had a hope for. Some were smart enough to 'stoploss'. Many including me missed that chance. A bad reactive PR didnt help the early result of a change to the WHO score for patients. Really too few patients for more than a trend.?.
Management did not say it would be the Bomb, but that ifenprodil may prove effective in some ways in the COVID battle. The H5N1 results as compared against other CC drugs showed promise, not knockouts. We all would appreciate info about ANY other drug showing a knockout punch at COVID.
Lots of Real Hype and disinformation with mildly successful (even Bad) results from all/anything else beyond SOC. On hindsight we all were wrong expecting that knockout and for not planning for less spectacular results.
All attempts to Treat COVID have basically been a 'Flop' no matter if it was Big Pharma or pumped by the highest 'bully pulpit'. Extreme EFFORTS by compassionate Nurses and Doctors under great Risk has been the most successful by far.
Early discussions here were of Ifenprodil joining in as a 'cocktail' Treatment. That is the bar and has been / will be until some treatments show stronger successes. JMHO...GLTA...

DrE, I read your post twice, Thanks for the effort.